Cognitive functional therapy with or without movement sensor biofeedback versus usual care for chronic, disabling low back pain (RESTORE): a randomised, controlled, three-arm, parallel group, phase 3, clinical trial.
OrthoEvidence Journal (OE Journal) - ACE Report
OE Journal. 2023;11(16):5 Lancet. 2023 Jun 3;401(10391): 1866-1877.What this means for my practice?
Cognitive functional therapy provided clinically meaningful improvements in function compared to usual care, which were sustained up to 1 year post-treatment. While no significant benefit was found with the use of biofeedback sensors, the results of this study indicate a cost-effective, clinical benefit of cognitive functional therapy vs. existing therapies for the treatment of chronic low back pain. This study was limited by restricted access to patient data, in particular cost data, and the lack of standardization in the control group.
Study Summary
492 patients with chronic, disabling low back pain were randomized to receive cognitive functional therapy (CFT) with the use of biofeedback sensors (n=163) or without biofeedback sensors (n=164), or usual care (n=165). The primary outcome of interest was pain-related physical activity limitation. Secondary outcomes of interest included pain outcomes, functional limitation, global improvement, patient satisfaction, adverse events, and cost-utility. Follow-up was conducted over a 52 week period. Both CFT groups significantly outperformed the usual care group in all outcomes, resulting in greater improvements in physical function, pain relief, improvement in outcomes, and fear avoidance, up to 52 weeks. Moreover, the CFT groups were significantly more cost-effective than the usual care group, resulting in a greater gain in quality adjusted life-years and a larger reduction in productivity loss. However, the use of CFT with biofeedback sensors did not result in any meaningful difference over CFT only. The results of this trial suggest that CFT could provide lasting, effective relief of chronic, disabling low back pain in a cost-effective manner vs. existing treatments.
Unlock the Full ACE Report
You have access to 4 more FREE articles this month.
Click below to unlock and view this ACE Reports
Unlock Now
Critical appraisals of the latest, high-impact randomized controlled trials and systematic reviews in orthopaedics
Access to OrthoEvidence podcast content, including collaborations with the Journal of Bone and Joint Surgery, interviews with internationally recognized surgeons, and roundtable discussions on orthopaedic news and topics
Subscription to The Pulse, a twice-weekly evidence-based newsletter designed to help you make better clinical decisions
Exclusive access to original content articles, including in-house systematic reviews, and articles on health research methods and hot orthopaedic topics
Or upgrade today and gain access to all OrthoEvidencecontent for as little as $1.99 per week.
Already have an account? Log in
Are you affiliated with one of our partner associations?
Click here to gain complimentary access as part your association member benefits!